The FDA Learning Cache

@UCAliTIhJ6stTjm8dFC0Ie-A - 385 subscribers

Preserve Science. Safeguard Knowledge. Defend Truth.

Home Videos Live Playlists

FDA ADEPT 10: Ethical Considerations in Neonatal and Rare Disease Clinical Trials (February 2026)

FDA ADEPT 10: Ethical Considerations in Neonatal and Rare Disease Clinical Trials (February 2026) The FDA Learning Cache

23 views - 4 weeks ago

FDA ADEPT 10: Innovative Strategies for Neonatal & Rare Disease Clinical Trials (Part 1) (Feb 2026)

FDA ADEPT 10: Innovative Strategies for Neonatal & Rare Disease Clinical Trials (Part 1) (Feb 2026) The FDA Learning Cache

31 views - 4 weeks ago

FDA ADEPT 10: Innovative Strategies for Neonatal & Rare Disease Clinical Trials (Part 2) (Feb 2026)

FDA ADEPT 10: Innovative Strategies for Neonatal & Rare Disease Clinical Trials (Part 2) (Feb 2026) The FDA Learning Cache

26 views - 4 weeks ago

FDA ADEPT 10: Regulatory Landscape & Future Directions for Neonatal & Rare Disease Drug Development

FDA ADEPT 10: Regulatory Landscape & Future Directions for Neonatal & Rare Disease Drug Development The FDA Learning Cache

39 views - 4 weeks ago

FDA ADEPT 10: Addressing Challenges in Neonatal Product Development: Summary and Closing Remarks

FDA ADEPT 10: Addressing Challenges in Neonatal Product Development: Summary and Closing Remarks The FDA Learning Cache

21 views - 4 weeks ago

FDA ADEPT 10: Setting the Scene – Neonatal and Rare Disease Drug Development (February 2026)

FDA ADEPT 10: Setting the Scene – Neonatal and Rare Disease Drug Development (February 2026) The FDA Learning Cache

24 views - 4 weeks ago

FDA ADEPT 10: Addressing Challenges in Neonatal Product Development: Welcome & Introductory Remarks

FDA ADEPT 10: Addressing Challenges in Neonatal Product Development: Welcome & Introductory Remarks The FDA Learning Cache

38 views - 4 weeks ago

FDA Postmarket Regulation of Cosmetic Products: Q&A Panel

FDA Postmarket Regulation of Cosmetic Products: Q&A Panel The FDA Learning Cache

10 views - 4 weeks ago

FDA Postmarket Regulation of Cosmetic Products: Adverse Event Reporting

FDA Postmarket Regulation of Cosmetic Products: Adverse Event Reporting The FDA Learning Cache

47 views - 4 weeks ago

FDA Registration and Listing of Cosmetic Product Facilities and Products

FDA Registration and Listing of Cosmetic Product Facilities and Products The FDA Learning Cache

100 views - 4 weeks ago

FDA Postmarket Regulation of Cosmetic Products: The Who, What, When, Why and How

FDA Postmarket Regulation of Cosmetic Products: The Who, What, When, Why and How The FDA Learning Cache

100 views - 4 weeks ago

FDA Improving Anaphylaxis Outcomes: Session 4: Opportunities to Enhance Access & Use of Epinephrine

FDA Improving Anaphylaxis Outcomes: Session 4: Opportunities to Enhance Access & Use of Epinephrine The FDA Learning Cache

38 views - 3 months ago

FDA Improving Anaphylaxis Outcomes: Session 3: Current Accessibility to Epinephrine

FDA Improving Anaphylaxis Outcomes: Session 3: Current Accessibility to Epinephrine The FDA Learning Cache

38 views - 3 months ago

FDA Improving Anaphylaxis Outcomes: Session 2: Regulatory Pathways for Epinephrine Products

FDA Improving Anaphylaxis Outcomes: Session 2: Regulatory Pathways for Epinephrine Products The FDA Learning Cache

80 views - 3 months ago

FDA Improving Anaphylaxis Outcomes: Opening & Session 1: Allergic Diseases, Anaphylaxis, & Treatment

FDA Improving Anaphylaxis Outcomes: Opening & Session 1: Allergic Diseases, Anaphylaxis, & Treatment The FDA Learning Cache

78 views - 3 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Presentations

FDA Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Presentations The FDA Learning Cache

311 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Q&A Panel

FDA Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Q&A Panel The FDA Learning Cache

85 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Presentations

FDA Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Presentations The FDA Learning Cache

285 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development - Q&A Panel

FDA Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development - Q&A Panel The FDA Learning Cache

122 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development - Presentations

FDA Modeling and AI in Generic Drug Development 2025: AI Supporting Drug Development - Presentations The FDA Learning Cache

249 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Q&A Panel

FDA Modeling and AI in Generic Drug Development 2025: AI Streamlining Workflows – Q&A Panel The FDA Learning Cache

39 views - 5 months ago

FDA Modeling and AI in Generic Drugs 2025: Regulatory Perspectives and Opportunities – Q&A Panel

FDA Modeling and AI in Generic Drugs 2025: Regulatory Perspectives and Opportunities – Q&A Panel The FDA Learning Cache

93 views - 5 months ago

FDA Modeling and AI in Generic Drugs 2025: Regulatory Perspectives and Opportunities – Presentations

FDA Modeling and AI in Generic Drugs 2025: Regulatory Perspectives and Opportunities – Presentations The FDA Learning Cache

279 views - 5 months ago

FDA Modeling and AI in Generic Drug Development 2025: Welcome and Opening Remarks

FDA Modeling and AI in Generic Drug Development 2025: Welcome and Opening Remarks The FDA Learning Cache

280 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Session 4: Q&A Panel and Day Two Closing

FDA Advancing Generic Drug Development 2025: Session 4: Q&A Panel and Day Two Closing The FDA Learning Cache

65 views - 5 months ago

FDA Advancing Generic Drugs 2025: Pharm/Tox for the Safety Evaluation of Nitrosamine Impurities

FDA Advancing Generic Drugs 2025: Pharm/Tox for the Safety Evaluation of Nitrosamine Impurities The FDA Learning Cache

86 views - 5 months ago

FDA Advancing Generic Drugs 2025: Potential Pitfalls in Nitrosamine Risk Assessment and Control

FDA Advancing Generic Drugs 2025: Potential Pitfalls in Nitrosamine Risk Assessment and Control The FDA Learning Cache

120 views - 5 months ago

FDA Advancing Generic Drugs 2025: Nitrosamine Impacted Drugs Containing BCS IV Drug Substances

FDA Advancing Generic Drugs 2025: Nitrosamine Impacted Drugs Containing BCS IV Drug Substances The FDA Learning Cache

74 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Session 3: Q&A Panel

FDA Advancing Generic Drug Development 2025: Session 3: Q&A Panel The FDA Learning Cache

68 views - 5 months ago

FDA Advancing Generic Drugs 2025: Comparative Physicochemical Characterization of Iron Products

FDA Advancing Generic Drugs 2025: Comparative Physicochemical Characterization of Iron Products The FDA Learning Cache

102 views - 5 months ago

FDA Advancing Generic Drugs 2025: Glatiramer Acetate Injectable & Pentosan Polysulfate Capsules

FDA Advancing Generic Drugs 2025: Glatiramer Acetate Injectable & Pentosan Polysulfate Capsules The FDA Learning Cache

103 views - 5 months ago

FDA Advancing Generic Drugs 2025: Developing the Oral Semaglutide Product-Specific Guidance

FDA Advancing Generic Drugs 2025: Developing the Oral Semaglutide Product-Specific Guidance The FDA Learning Cache

170 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Compositional Sameness for Complex Polymeric Excipients

FDA Advancing Generic Drug Development 2025: Compositional Sameness for Complex Polymeric Excipients The FDA Learning Cache

58 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Session 2: Q&A Panel and Day 1 Closing

FDA Advancing Generic Drug Development 2025: Session 2: Q&A Panel and Day 1 Closing The FDA Learning Cache

41 views - 5 months ago

FDA Advancing Generic Drugs 2025: Extrapolation of PK BE to an Alternative Comparator

FDA Advancing Generic Drugs 2025: Extrapolation of PK BE to an Alternative Comparator The FDA Learning Cache

83 views - 5 months ago

FDA Advancing Generic Drugs 2025: Population Selection and Mitigation Strategies in BE Studies

FDA Advancing Generic Drugs 2025: Population Selection and Mitigation Strategies in BE Studies The FDA Learning Cache

64 views - 5 months ago

FDA Advancing Generic Drugs 2025: Correct Carryover for Long Half-Life Drug with Incomplete Washout

FDA Advancing Generic Drugs 2025: Correct Carryover for Long Half-Life Drug with Incomplete Washout The FDA Learning Cache

67 views - 5 months ago

FDA Advancing Generic Drugs 2025: Degradation Challenges in BCS Class III Biowaiver Applications

FDA Advancing Generic Drugs 2025: Degradation Challenges in BCS Class III Biowaiver Applications The FDA Learning Cache

28 views - 5 months ago

FDA Advancing Generic Drugs 2025: Biopharmaceutics Classification System Waiver Option in PSGs

FDA Advancing Generic Drugs 2025: Biopharmaceutics Classification System Waiver Option in PSGs The FDA Learning Cache

60 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Session 1: Q&A Panel

FDA Advancing Generic Drug Development 2025: Session 1: Q&A Panel The FDA Learning Cache

36 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Recommendations for Topical and Mucosal Products

FDA Advancing Generic Drug Development 2025: Recommendations for Topical and Mucosal Products The FDA Learning Cache

37 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Metered Dose Inhaler & Dry Powder Inhaler Update

FDA Advancing Generic Drug Development 2025: Metered Dose Inhaler & Dry Powder Inhaler Update The FDA Learning Cache

52 views - 5 months ago

FDA Advancing Generic Drug Development 2025: SME Triage Team Case Study: Complex Implant Products

FDA Advancing Generic Drug Development 2025: SME Triage Team Case Study: Complex Implant Products The FDA Learning Cache

47 views - 5 months ago

FDA Advancing Generic Drug Development 2025: SME Triage Team: Product-Specific Guidance Development

FDA Advancing Generic Drug Development 2025: SME Triage Team: Product-Specific Guidance Development The FDA Learning Cache

47 views - 5 months ago

FDA Advancing Generic Drug Development 2025: Welcome & Keynote

FDA Advancing Generic Drug Development 2025: Welcome & Keynote The FDA Learning Cache

170 views - 5 months ago

FDA-CRCG Mastering Particle Size Analysis Workshop: Day Two Q&A Session with Panel & Closing

FDA-CRCG Mastering Particle Size Analysis Workshop: Day Two Q&A Session with Panel & Closing The FDA Learning Cache

61 views - 6 months ago

FDA Mastering Particle Size Analysis Workshop: Industry Perspectives on Particle Size Measurement

FDA Mastering Particle Size Analysis Workshop: Industry Perspectives on Particle Size Measurement The FDA Learning Cache

147 views - 6 months ago

$FDA-CRCG Mastering Particle Size Analysis Workshop: Vendor Perspectives for Laser Diffraction$ 36:51

FDA-CRCG Mastering Particle Size Analysis Workshop: Vendor Perspectives for Laser Diffraction The FDA Learning Cache

51 views - 6 months ago

$FDA-CRCG Mastering Particle Size Analysis Workshop: Laser Diffraction (LD) Theory and Practice$ 55:41

FDA-CRCG Mastering Particle Size Analysis Workshop: Laser Diffraction (LD) Theory and Practice The FDA Learning Cache

122 views - 6 months ago

FDA-CRCG Mastering Particle Size Analysis Workshop: Vendor Perspectives for Dynamic Light Scattering

FDA-CRCG Mastering Particle Size Analysis Workshop: Vendor Perspectives for Dynamic Light Scattering The FDA Learning Cache

70 views - 6 months ago

FDA-CRCG Mastering Particle Size Analysis Workshop: Day One Q&A Session with Panel

FDA-CRCG Mastering Particle Size Analysis Workshop: Day One Q&A Session with Panel The FDA Learning Cache

24 views - 6 months ago

FDA Particle Size Analysis: Dynamic Light Scattering Theory, Practice, and Regulatory Perspectives

FDA Particle Size Analysis: Dynamic Light Scattering Theory, Practice, and Regulatory Perspectives The FDA Learning Cache

177 views - 6 months ago

FDA-CRCG Mastering Particle Size Analysis Workshop: Welcome, Opening Remarks, and Workshop Overview

FDA-CRCG Mastering Particle Size Analysis Workshop: Welcome, Opening Remarks, and Workshop Overview The FDA Learning Cache

119 views - 6 months ago

FDA Interchangeable Products Workshop: Panel Discussion, Summary, and Close Out

FDA Interchangeable Products Workshop: Panel Discussion, Summary, and Close Out The FDA Learning Cache

45 views - 6 months ago

FDA Interchangeable Products: Other Considerations Around Interchangeability of Biological Products

FDA Interchangeable Products: Other Considerations Around Interchangeability of Biological Products The FDA Learning Cache

30 views - 6 months ago

FDA Interchangeable Workshop: User Interface & Human Factor Considerations Around Interchangeability

FDA Interchangeable Workshop: User Interface & Human Factor Considerations Around Interchangeability The FDA Learning Cache

31 views - 6 months ago

FDA Interchangeable Products: Analytical Considerations Around Interchangeability of a Biologic

FDA Interchangeable Products: Analytical Considerations Around Interchangeability of a Biologic The FDA Learning Cache

32 views - 6 months ago

FDA Interchangeable Products Workshop: Landscape of Stakeholder Perspectives

FDA Interchangeable Products Workshop: Landscape of Stakeholder Perspectives The FDA Learning Cache

52 views - 6 months ago

FDA Future Needs for the Development of Interchangeable Products: Opening Remarks & Keynote Address

FDA Future Needs for the Development of Interchangeable Products: Opening Remarks & Keynote Address The FDA Learning Cache

112 views - 6 months ago

FDA Compounding Quality Center of Excellence Annual Conference 2025: Introduction to Water Systems

FDA Compounding Quality Center of Excellence Annual Conference 2025: Introduction to Water Systems The FDA Learning Cache

33 views - 6 months ago